D
BMY icon

Diversified’s Bristol-Myers Squibb BMY Stock Holding History

Diversified’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,197
Closed -$228K – 235
2024
Q1 		$228K Buy
+4,197
New +$214K 0.03% 154
2023
Q4 		– Sell
-4,287
Closed -$249K – 159
2023
Q3 		$249K Buy
4,287
+398
+10% +$24.4K 0.06% 120
2023
Q2 		$249K Sell
3,889
-146
-4% -$9.79K 0.06% 122
2023
Q1 		$280K Buy
4,035
+16
+0.4% +$1.13K 0.1% 112
2022
Q4 		$289K Buy
4,019
+369
+10% +$27.8K 0.11% 113
2022
Q3 		$259K Buy
+3,650
New +$265K 0.13% 95
2021
Q1 		– Sell
-2,431
Closed -$147K – 118
2020
Q4 		$147K Buy
+2,431
New +$149K 0.13% 103

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Diversified's BMY Position: Q2 2024 in Review

Diversified sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 4,197 shares — an estimated $228K sold.

Diversified first reported a position in BMY in Q4 2020 and held it in 7 quarters. The position peaked at $289K in Q4 2022. 2,149 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Diversified reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Diversified sold 4,197 Bristol-Myers Squibb shares in Q2 2024, an estimated $228K.
  • Diversified first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 7 quarters.
  • Diversified's Bristol-Myers Squibb position peaked at $289K in Q4 2022.
  • 2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Diversified's 13F filing for Q2 2024, filed 24 Jul 2024.